Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0012044747
Wed, 14.10.2020
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
SHOP APOTHEKE EUROPE N.V. ANNOUNCES REDEMPTION OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
Venlo, 1 [ … ]
Tue, 06.10.2020
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
SHOP APOTHEKE EUROPE N.V. ENDS DISCUSSIONS AND ANNOUNCES CLEAN-UP OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS [ … ]
Mon, 05.10.2020
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.SHOP APOTHEKE EUROPE grows by 39.7% in Q3.
Preliminary sales growth of 39.7% to EUR 238.7 million in Q3 and of 38.1 [ … ]
Wed, 30.09.2020
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
SHOP APOTHEKE EUROPE N.V. ANNOUNCES UPDATE ON DISCUSSIONS ABOUT ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2 [ … ]
Wed, 23.09.2020
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
SHOP APOTHEKE EUROPE N.V. ANNOUNCES TO START DISCUSSIONS OF A POSSIBLE EARLIER CONVERSION OF ITS EUR 135 MILLION [ … ]
Mon, 21.09.2020
SHOP APOTHEKE EUROPE N.V.
NOT FOR PUBLICATION OR DISTRIBUTION IN THE USA, CANADA, AUSTRALIA AND JAPAN.
SHOP APOTHEKE EUROPE promoted to MDAX.
Venlo, the Netherlands, 21 September 2020. The shares of SHOP APOTHEKE EUROPE are now listed in the MDAX selection index following the latest index review by Deutsche Börse.
With its promotion to the MDAX, SHOP APOTHEKE EUROPE [ … ]
Thu, 06.08.2020
SHOP APOTHEKE EUROPE N.V.
SHOP APOTHEKE EUROPE: 42% growth and significantly improved bottom line in Q2; adjusted Q2 EBITDA margin 2.7%.
Increased market shares with outstanding sales growth of 42% in Q2 and 37% in H1, both fully organic.
Record number of new customers; active base up 1.3 million year over year to 5.5 million.
DACH segment increased sales by 33% in Q2 an [ … ]